Ekam Imaging Inc. is a contract research organization (CRO) whose preclinical imaging and analysis services and products help pharmaceutical and biotechnology companies, universities and other medical research organizations to improve the safety and efficacy of new therapeutics and reduce the cost and risk of clinical trials.    

Key to Ekam’s success, value proposition and point of differentiation is the translational information generated from being the only CRO performing studies on awake rodents and non-human primates providing an approach to evaluating the circuitry that underlies the behavioral effects of a drug.  With a unique business model and in partnership with the Center for Translational Neuro-Imaging at Northeastern University in Boston, Ekam provides the industry with the technology and expertise that can provide a true translational bridge between preclinical and clinical studies in a cost effective manner without the challenges associated with academic partnerships.

Our commitment is to focus our skills and experience with complete dedication to our clients' success.